Laura Rubio Arrieta

Title: Laura Rubio Arrieta: Innovator in Neurodegenerative Disease Treatment

Introduction

Laura Rubio Arrieta is a prominent inventor based in Tres Cantos, Spain. She has made significant contributions to the field of medicine, particularly in the treatment of neurodegenerative and hematological diseases. With a total of 2 patents, her work is paving the way for new therapeutic options.

Latest Patents

One of her latest patents involves the development of [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or hematological diseases. This invention relates to a new family of compounds that are useful for treating or preventing these conditions. The patent outlines their use as a medicament and includes a pharmaceutical composition comprising these compounds.

Another notable patent focuses on acetylcholinesterase dual inhibitors. This invention provides compounds that have a tacrine moiety connected to a heterocyclic moiety through a linker. By carefully selecting the substituents and the linker, the activity and selectivity towards acetylcholinesterase can be modulated. These compounds exhibit potent AChE inhibition activities and show promise in treating AChE-mediated diseases, such as Alzheimer's disease.

Career Highlights

Laura has worked with several companies, including Noscira, S.A. and Neuropharma S.A.U. Her experience in these organizations has contributed to her expertise in the field of neurodegenerative diseases.

Collaborations

Laura has collaborated with notable professionals in her field, including Ana Martinez Gil and Miguel Medina Padilla. These partnerships have enhanced her research and development efforts.

Conclusion

Laura Rubio Arrieta is a trailblazer in the field of neurodegenerative disease treatment, with innovative patents that hold great potential for future medical applications. Her contributions are significant in advancing therapeutic options for patients.